Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 16/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoleucine SCHEMBL480974 | 1.00 | DPP4 (0.43) | DPP4DPP8DPP9DPP7SLC7A5 | |
| Isoleucine SCHEMBL6872156 | 0.93 | DPP4 (0.39) | DPP4DPP8DPP9DPP7 | |
| Isoleucine SCHEMBL6872155 | 0.93 | DPP4 (0.39) | DPP4DPP8DPP9DPP7 | |
| Isoleucine SCHEMBL6872158 | 0.93 | DPP4 (0.39) | DPP4DPP8DPP9DPP7 | |
| Isoleucine SCHEMBL391313 | 0.85 | DPP4 (0.70) | DPP4DPP8DPP9DPP7 | |
| Valine SCHEMBL5604912 | 0.83 | SLC7A5 (0.54) | DPP4DPP8DPP7SLC7A5 | |
| Isoleucine SCHEMBL4468657 | 0.78 | DPP4 (0.42) | DPP4DPP8DPP9DPP7SLC7A5 | |
| Isoleucine SCHEMBL6428278 | 0.78 | DPP4 (0.42) | DPP4DPP8DPP9DPP7SLC7A5 | |
| Isoleucine SCHEMBL4468654 | 0.78 | DPP4 (0.42) | DPP4DPP8DPP9DPP7SLC7A5 | |
| Isoleucine SCHEMBL20340795 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1841 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3565573-B1 | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-08-23 | — | — | EP | claimed |
| EP-3565573-A2 | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | The Regents of The University of California (US) | 2019-11-13 | — | — | EP | claimed |
| US-20190322718-A1 | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | THE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2019-10-24 | — | — | US | claimed |
| CN-110300595-A | PAC1 receptor stimulating agent (MAXCAP) and application thereof | 加利福尼亚大学董事会 | 2019-10-01 | — | — | CN | claimed |
| WO-2018129200-A2 | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-07-12 | — | — | WO | claimed |
| US-20120020930-A1 | METHODS FOR THE PREPARATION OF ADIPOSE DERIVED STEM CELLS AND UTILIZING SAID CELLS IN THE TREATMENT OF DISEASES | CELLERIX, S.A. (ES) | 2012-01-26 | — | — | US | claimed |
| US-20110294735-A1 | MECHANISM OF NEUROMEDIN U ACTION AND USES THEREOF | MERCK SHARP & DOHME CORP. (US) | 2011-12-01 | — | — | US | claimed |
| EP-2352512-A1 | MECHANISM OF NEUROMEDIN U ACTION AND USES THEREOF | Merck Sharp & Dohme Corp. (US) | 2011-08-10 | — | — | EP | claimed |
| WO-2010053830-A1 | MECHANISM OF NEUROMEDIN U ACTION AND USES THEREOF | MERCK SHARP & DOHME CORP. (US) | 2010-05-14 | — | — | WO | claimed |
| CN-101563103-A | Novel nematode protein and its use in producing anthelminthic agents and vaccines | MOREDUN RES INST (GB) | 2009-10-21 | — | — | CN | claimed |
| EP-1448523-B1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | NOVARTIS AG (CH) | 2007-08-22 | — | — | EP | claimed |
| US-20070032420-A1 | Treating diabetes with glucagon-like peptide-1 secretagogues | ENTELOS, INC. | 2007-02-08 | — | — | US | claimed |
| WO-2006086727-A2 | TREATING DIABETES WITH GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUES | ENTELOS, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| US-7078397-B2 | Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-18 | — | — | US | claimed |
| CN-1596120-A | Pharmaceutical composition for transnasal absorption | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2005-03-16 | — | — | CN | claimed |
| US-20050014681-A1 | Medicinal compositions for nasal absorption | ASUBIO PHARMA CO., LTD. (JP) | 2005-01-20 | — | — | US | claimed |
| EP-1466610-A1 | MEDICINAL COMPOSITIONS FOR NASAL ABSORPTION | Daiichi Suntory Pharma Co., Ltd. (JP) | 2004-10-13 | — | — | EP | claimed |
| US-20030096328-A1 | Serine/threonine hydrolase proteins and screening assays | BURNHAM INSTITUTE | 2003-05-22 | — | — | US | claimed |
| WO-2003023355-A2 | SERINE/THREONINE HYDROLASE PROTEINS AND SCREENING ASSAYS | THE BURNHAM INSTITUTE (US) | 2003-03-20 | — | — | WO | claimed |
| WO-2003017936-A2 | USE OF DPPIV INHIBITORS AS DIURETIC AND ANTI-HYPERTENSIVE AGENTS | YALE UNIVERSITY (US) | 2003-03-06 | — | — | WO | claimed |